Progress and controversy in Alzheimer's research: Aducanumab's FDA…
Medical News Today,
The number of people with Alzheimer’s disease is increasing rapidly. Some hail human monoclonal antibodies that clear beta-amyloi…
The number of people with Alzheimer’s disease is increasing rapidly. Some hail human monoclonal antibodies that clear beta-amyloi…
The amyloid-beta antibody aducanumab was issued a “negative trend vote” by European regulators, announced its developer Biogen…
A new drug for the treatment of Alzheimer’s disease should be given to a much narrower group of patients than the federal…